投稿信息
投稿信息
审稿周期
投稿命中率
审稿费用
暂无数据
版面费用
暂无数据
中国人发表比例
2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%)
自引率
4.0 %
年文章数
977
NCBI查询
期刊简介
稿件收录要求
稿件收录要求
Apoptosis is an international peer-reviewed journal published bimonthly. The Journal is devoted to the rapid publication of innovative basic and clinically-oriented investigations into programmed cell death. It aims to stimulate both research on the basis of mechanisms of apoptosis and on its role in various human disease processes including: cancer autoimmune disease viral infection AIDS cardiovascular disease neurodegenerative disorders osteoporosis and ageing. The Editor-In-Chief recognises the need to encourage the development of clinical therapies against apoptosis-related diseases.
Apoptosis is a peer-reviewed journal devoted to basic and clinically-oriented investigations into programmed cell death.
- Stimulates research on the basis of mechanisms of apoptosis and its role in various human disease processes.
- Investigates links to cancer, autoimmune disease, viral infection, AIDS, cardiovascular disease, neurodegenerative disorders, osteoporosis and ageing.
- Encourages development of clinical therapies against apoptosis-related diseases.
- 90% of authors who participated in a survey reported they would likely publish in the journal again.
- Editor-in-Chief
-
- Arjan W. Griffioen,
- Patrycja Nowak-Sliwinska
- Impact factor
- 7.2 (2022)
- 5 year impact factor
- 5.9 (2022)
- Submission to first decision (median)
- 8 days
- Downloads
- 320,711 (2022)
